share_log

康辰药业董事会关于2023年年报审计报告强调事项段涉及事项消除的专项说明

The board of directors of Beijing Konruns Pharmaceutical emphasized the special instructions on the elimination of the matters involved in the section of the audit report on the 2023 annual report.

SZSI ·  Jul 3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more